Adverse Events Definition Should Be Narrower, IRB Groups Tell FDA
This article was originally published in The Pink Sheet Daily
Executive Summary
The Consortium of Independent Review Boards favors reporting only adverse events that "probably or definitely" related to the study drug. Current regulation requires adverse events to be reported to IRBs if they are "at least possibly" related to the drug.